Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Durect Headed in Right Direction - Analyst Blog
Nov 04, 2008 05:02 PM
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM
- Analyst Comments: Autoliv, Fred, IPC Holdings, Durect, Williams Companies, Korea Electric Power, Anaren
Aug 31, 2008 02:49 PM
- Optimistic on Durect Pipeline
Jun 26, 2008 05:01 PM
- Analyst Comments: Royal Dutch, Exxon, Durect, American Public Education, Interstate Hotels, Drugstore.com, Georgia Gulf
May 09, 2008 12:20 PM
- NASDAQ Technical Picture - Bearish Outside Day
May 08, 2008 01:10 AM
- Endo Pharma Holdings Withdrew SNDA For Frova 2.5mg Tablets
Apr 07, 2008 06:36 PM
- Analyst Comments: 3Com Corp, Jabil Circuit, Durect Corporation, Intevac, GlaxoSmithKline
Mar 27, 2008 07:08 PM
- Morning Earnings Summary
Feb 06, 2008 01:09 PM
- Retail Sales, Subprime, Rates & Jobs
Dec 06, 2007 10:14 AM
- DURECT Corporation to Participate in Upcoming Healthcare Conferences
Nov 26, 2008 09:01 AM
- Zacks Analyst Blog Highlights: NovaMed, Inc., RC2 Corp., Durect Corp., P.T. Telekomunikasi Indonesia Tbk and Embotelladora Andina S.A.
Nov 06, 2008 01:23 AM
- DURECT Corporation Announces Third Quarter 2008 Financial Results
Nov 03, 2008 04:05 PM
- DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective
Oct 29, 2008 07:01 AM
- Alpharma Reports Third Quarter 2008 EPS of $0.10
Oct 29, 2008 07:00 AM
- DURECT Corporation to Participate in Upcoming Healthcare Conferences
Oct 28, 2008 09:02 AM
- DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
Oct 27, 2008 08:50 AM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: INCY, DRRX, MDRX, NKTR, PRGN, AFFX
Oct 21, 2008 09:03 AM
- Zacks Analyst Blog Highlights: Johnson & Johnson, CarMax, Inc., Rackable Systems, Inc., DURECT Corp. And Alpharma Inc.
Oct 20, 2008 01:13 AM
- Alpharma to Develop and Commercialize DURECT's ELADUR(TM) Pain Patch
Sep 22, 2008 07:01 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
DRRX
|
Compare to S&P
|
| YTD |
-34.68 %
|
7.02 %
|
| 4 Weeks |
2.19 %
|
10.46 %
|
| 12 Weeks |
-20.45 %
|
10.26 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 0.00 %
|
|
Sales Growth in Last Quarter: 5.25 %
|
|
Sales Growth in Last Quarter: 34.51 %
|
|
|
